Clinical Trial Results

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

NAINTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus

N/AOBSERVATIONAL Manhasset, New York

RECRUITING

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

N/AOBSERVATIONAL La Jolla, California +4 more

RECRUITING

Study of Systemic Lupus Erythematosus

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Systemic Lupus Erythematosus in Gullah Health

N/AOBSERVATIONAL Charleston, South Carolina

RECRUITING

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

N/AOBSERVATIONAL Baltimore, Maryland +4 more

RECRUITING

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

N/AOBSERVATIONAL Chicago, Illinois +4 more

RECRUITING

Lupus Landmark Study: A Prospective Registry and Biorepository

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

N/AOBSERVATIONAL Philadelphia, Pennsylvania +1 more

RECRUITING

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

N/AOBSERVATIONAL Waltham, Massachusetts

RECRUITING

Research Accelerated by You Lupus Registry

N/AOBSERVATIONAL Washington D.C., District of Columbia

RECRUITING

Duke Lupus Registry

N/AOBSERVATIONAL Durham, North Carolina

RECRUITING

Cutaneous Lupus Registry

N/AOBSERVATIONAL Dallas, Texas

RECRUITING

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Transcutaneous Vagus Nerve Stimulation in SLE

PHASE2INTERVENTIONAL Manhasset, New York

RECRUITING

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

PHASE1, PHASE2INTERVENTIONAL Little Rock, Arkansas +4 more

RECRUITING

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

PHASE4INTERVENTIONAL Las Vegas, Nevada

RECRUITING

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

PHASE1INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

PHASE1INTERVENTIONAL La Jolla, California +4 more

RECRUITING

US Zamto-cel Autoimmune Diseases

PHASE1INTERVENTIONAL Milwaukee, Wisconsin

RECRUITING

REACT-01: Reversing Autoimmunity Through Cell Therapy

PHASE1INTERVENTIONAL Seattle, Washington

RECRUITING

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Anifrolumab Pregnancy Study

N/AOBSERVATIONAL Cary, North Carolina

RECRUITING